Boston Research & Management’s Masco MAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Hold
4,000
0.07% 99
2026
Q1
$241K Hold
4,000
0.06% 107
2025
Q4
$254K Hold
4,000
0.06% 110
2025
Q3
$282K Hold
4,000
0.06% 105
2025
Q2
$257K Hold
4,000
0.06% 105
2025
Q1
$278K Hold
4,000
0.07% 99
2024
Q4
$290K Hold
4,000
0.07% 101
2024
Q3
$335K Hold
4,000
0.08% 99
2024
Q2
$266K Hold
4,000
0.07% 106
2024
Q1
$315K Hold
4,000
0.08% 103
2023
Q4
$267K Hold
4,000
0.07% 104
2023
Q3
$213K Hold
4,000
0.06% 109
2023
Q2
$229K Buy
+4,000
New +$209K 0.06% 105
2022
Q3
Sell
-4,000
Closed -$202K 104
2022
Q2
$202K Hold
4,000
0.07% 105
2022
Q1
$204K Hold
4,000
0.06% 110
2021
Q4
$280K Hold
4,000
0.08% 99
2021
Q3
$222K Hold
4,000
0.07% 104
2021
Q2
$235K Hold
4,000
0.07% 103
2021
Q1
$239K Hold
4,000
0.08% 101
2020
Q4
$219K Hold
4,000
0.08% 100
2020
Q3
$220K Hold
4,000
0.09% 96
2020
Q2
$200K Buy
+4,000
New +$173K 0.08% 96

Other funds holding MAS

Boston Research & Management's MAS Position: Q2 2026 in Review

Boston Research & Management held its Masco (MAS) position steady in Q2 2026 at 4,000 shares worth $325K. The position accounts for 0.07% of the portfolio, ranked #99.

Boston Research & Management first reported a position in MAS in Q2 2020 and has held it in 22 quarters since. The position peaked at $335K in Q3 2024. 920 funds tracked by Wall St. Rank hold MAS as of Q2 2026.

  • Boston Research & Management held 4,000 shares of Masco worth $325K as of Q2 2026.
  • Boston Research & Management left its Masco share count unchanged in Q2 2026.
  • Masco made up 0.07% of Boston Research & Management's portfolio in Q2 2026, its #99 holding.
  • Boston Research & Management first reported a position in Masco in Q2 2020 and has held it in 22 quarters since.
  • Boston Research & Management's Masco position peaked at $335K in Q3 2024.
  • 920 funds tracked by Wall St. Rank held Masco as of Q2 2026.

Based on Boston Research & Management's 13F filing for Q2 2026, filed 11 Aug 2026.